FDA Inspection 706191 — Greater Baltimore Medical Center

Greater Baltimore Medical Center — FEI 1173170

The FDA completed an inspection of Greater Baltimore Medical Center on January 18, 2011 in Towson, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 18, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Towson, MD (United States)

Citations

IDCFRDescription
1503021 CFR 606.60(b)Equipment calibration frequency
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs